91 related articles for article (PubMed ID: 12478895)
1. [Rapid inhibition of extracellular signal-regulated kinase 1/2 in a human ovarian cancer cell line by dexamethasone].
Xia B; Lu J
Ai Zheng; 2002 Aug; 21(8):868-71. PubMed ID: 12478895
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid modulation of extracellular signal-regulated protein kinase 1/2 and p38 in human ovarian cancer HO-8910 cells.
Xia B; Lu J; Wang G
Chin Med J (Engl); 2003 May; 116(5):753-6. PubMed ID: 12875695
[TBL] [Abstract][Full Text] [Related]
3. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
Yazlovitskaya EM; Pelling JC; Persons DL
Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.
Cui W; Yazlovitskaya EM; Mayo MS; Pelling JC; Persons DL
Mol Carcinog; 2000 Dec; 29(4):219-28. PubMed ID: 11170260
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
[TBL] [Abstract][Full Text] [Related]
6. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of inhibiting proliferation of human ovarian cancer cells of the line HO-8910 by dexamethasone: the role of RhoB signaling pathway].
Chen YX; Li ZB; Diao F; Wang Y; Lu J
Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1400-4. PubMed ID: 16796923
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2).
Zhang B; Fenton RG
J Cell Physiol; 2002 Oct; 193(1):42-54. PubMed ID: 12209879
[TBL] [Abstract][Full Text] [Related]
11. Cellular proliferative effect of dexamethasone in immortalized trabecular meshwork cell (TM5) line.
Jeon JW; Lee SJ; Kim JB; Kang JJ; Lee JH; Seong GJ; Kim EK
Yonsei Med J; 2003 Apr; 44(2):299-306. PubMed ID: 12728472
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
13. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
Murakami-Mori K; Mori S; Bonavida B; Nakamura S
J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
[TBL] [Abstract][Full Text] [Related]
14. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line.
Liu H; Huang X; Wang H; Shen A; Cheng C
Brain Res; 2009 Apr; 1265():1-12. PubMed ID: 19368818
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone in the presence of desipramine enhances MAPK/ERK1/2 signaling possibly via its interference with β-arrestin.
Lucki A; Klein E; Karry R; Ben-Shachar D
J Neural Transm (Vienna); 2014; 121(3):289-98. PubMed ID: 24132698
[TBL] [Abstract][Full Text] [Related]
17. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
18. Mast cell tryptase activates extracellular-regulated kinases (p44/p42) in airway smooth-muscle cells: importance of proteolytic events, time course, and role in mediating mitogenesis.
Brown JK; Jones CA; Rooney LA; Caughey GH
Am J Respir Cell Mol Biol; 2001 Feb; 24(2):146-54. PubMed ID: 11159048
[TBL] [Abstract][Full Text] [Related]
19. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.
Mertens-Walker I; Bolitho C; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Jun; 17(2):335-49. PubMed ID: 20215102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
